News
HC Wainwright & Co. Reiterates Buy on Hoth Therapeutics, Maintains $4 Price Target
5 Apr 24
News, Price Target, Reiteration, Analyst Ratings
EF Hutton Maintains Buy on Hoth Therapeutics, Raises Price Target to $7
2 Apr 24
News, Price Target, Analyst Ratings
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?
19 Mar 24
Biotech, News, Health Care, Movers, General
Market-Moving News for March 19th
19 Mar 24
Movers, Trading Ideas
Hoth Therapeutics Announces Data In Completed Study Of Alzheimer's Disease Pre-Clinical Treatment With HT-ALZ
19 Mar 24
Biotech, News, FDA, General
Hoth Therapeutics Engages Altasciences To Perform Study For HT-KIT Cancer Fighting Therapeutic
26 Feb 24
Biotech, News, General
HC Wainwright & Co. Initiates Coverage On Hoth Therapeutics with Buy Rating, Announces Price Target of $4
5 Feb 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
27 Mar 24
Offerings, Press Releases
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
27 Mar 24
Press Releases
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
19 Mar 24
Press Releases
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
29 Feb 24
Press Releases
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
26 Feb 24
Press Releases
Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
13 Feb 24
Press Releases